Brinks DEA Consulting LLC

Content
Downloadable Documents
Link Library
Link Library

Welcome to the Brinks DEA Content Portal

We’re glad to have you here! This space is designed to give you full access to our latest insights, resources, and discussions related to DEA compliance, consulting strategies, and industry best practices.

Feel free to explore all available content, including articles, case studies, tools, and updates. We encourage you to engage with the material—leave comments, share your thoughts, ask questions, and connect with fellow members. Your feedback and participation help us grow a stronger, more informed community.

Thank you for being part of Brinks DEA Consulting. Let’s collaborate, learn, and lead together.

DEA QUOTAS FOR CONTROLLED SUBSTANCES – HOW DEA CHANGED THE PROCESS FOR AMERICA’S DRUG MANUFACTURERS

Overview of DEA Quotas Within the Framework of the Controlled Substances Act The Controlled Substances Act (CSA) has been a key part of Federal law for more than 55 years.  One of the main purposes of the CSA is to establish a regulatory framework in which all legitimate handlers of

Will Ibogaine Be the New Trend in Psychedelic Therapy?

The psychedelic drug ibogaine has been in the news recently. Many news articles and podcasts have brought to light ibogaine’s potential use in the treatment of anxiety, depression, traumatic brain injuries, and substance use disorders. In this blog we explore the history and current control of ibogaine. Ibogaine’s Early History

When DEA Guidance Became Law: How EO 13891 Exposed a Hidden DEA Problem

Executive Order 13891 (EO 13891): Why It Was Issued and Why It Still Matters For many years, federal agencies have relied heavily on documents known as “guidance.” These guidance documents include policy statements, manuals, FAQs, and advisories meant to explain how federal agencies understand the law.  The Drug Enforcement Administration

Facebook
Twitter
LinkedIn